CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 05, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”) today notes the announcement issued by Sarborg Limited (“Sarborg”) regarding the filing of a U.S. provisional patent application relating to its proprietary AI Signature Agent.

CDT holds a 20% equity stake in Sarborg and views this filing as an important step in strengthening and formalising Sarborg’s intellectual property position.

Sarborg announced that a provisional patent application was filed with the United States Patent and Trademark Office on February 12, 2026, and has been assigned United States Patent Application No. 63/981,801. The application relates to Sarborg’s Signature Agent architecture and its methodology for encoding and analysing biological, chemical and industrial signatures to generate ranked, intelligence-driven outputs.

“As a 20% shareholder, we view the filing of Sarborg’s provisional patent application as an important milestone in the development and protection of its proprietary technology,” said Dr. Andrew Regan, Chief Executive of CDT. “We believe continued advancement of Sarborg’s intellectual property supports the scalability of its Signature Agent across multiple sectors and enhances its long-term growth profile.”

About CDT Equity Inc.

CDT Equity Inc. (NASDAQ: CDT) is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Originally established as Conduit Pharmaceuticals, the company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. Looking ahead, CDT are committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.